Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Total Liabilities
Entera Bio Ltd
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Liabilities
$1.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Liabilities
$5.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Liabilities
$96.7m
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
7%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Total Liabilities
$50.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
20%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Liabilities
$240.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Liabilities
₪15.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
25%
|
See Also
What is Entera Bio Ltd's Total Liabilities?
Total Liabilities
1.4m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Total Liabilities amounts to 1.4m USD.
What is Entera Bio Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-16%
Over the last year, the Total Liabilities growth was 1%. The average annual Total Liabilities growth rates for Entera Bio Ltd have been -27% over the past three years , -16% over the past five years .